Back
Day Range
$26.98
$28.38
52-Week Range
$7.73
$42.27
Volume
303,688
50D / 200D Avg
$28.03
/
$23.20
Prev Close
$27.08
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.1 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | -28.2 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$43.33
+55.2%
Low: $40.00
High: $47.00
Forward EPS
-$3.36
Est. Revenue
13 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$3.58
-$3.58 – -$3.58
|
66 M | 1 |
| FY2029 |
-$4.74
-$4.74 – -$4.74
|
30 M | 1 |
| FY2028 |
-$4.77
-$5.47 – -$3.28
|
0 | 5 |
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -88.09M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-28.22%
ROIC-18.91%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.02
Current Ratio26.17
Interest Coverage0.00
Valuation
P/E Ratio
-9.14
P/B Ratio2.10
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -111.48M |
| ROE | -28.22% | ROA | -21.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -88.09M |
| ROIC | -18.91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 26.17 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.14 | P/B Ratio | 2.10 |
| P/S Ratio | N/A | PEG Ratio | -0.02 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.02B | Enterprise Value | 977.49M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -111.48M | -78.31M | -34.79M | -10.65M |
| EPS (Diluted) | -2.86 | -0.38 | -0.19 | -0.05 |
| Gross Profit | -1.02M | -839,000.0 | -112,000.0 | -15,000.0 |
| Operating Income | -125.10M | -83.06M | -36.18M | -10.37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 512.43M | 314.93M | 155.42M | 31.60M |
| Total Liabilities | 27.78M | 9.51M | 181.06M | 12.10M |
| Shareholders' Equity | 484.65M | 305.43M | -25.63M | 19.51M |
| Total Debt | 11.48M | 1.48M | 2.15M | 10.44M |
| Cash & Equivalents | 52.65M | 56.81M | 70.17M | 31.16M |
| Current Assets | 498.56M | 309.80M | 150.87M | 31.27M |
| Current Liabilities | 19.05M | 8.77M | 8.80M | 1.66M |